Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 29, 2026

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
11:49

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye

Published on: August 16, 2014

16.5K

Vimentin knockdown decreases corneal opacity.

Subrata K Das1, Isha Gupta1, Yang Kyung Cho2

  • 1Department of Ophthalmology, Moran Eye Center, University of Utah, Salt Lake City, Utah, United States.

Investigative Ophthalmology & Visual Science
|May 24, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulsed accelerated corneal cross-linking for pediatric keratoconus: a prospective study from the Indian subcontinent.

International ophthalmology·2026
Same author

Issue regarding E Log book for PG students: Paper to pixels.

Indian journal of ophthalmology·2026
Same author

Design and Implementation of a Field Programmable Gate Array-Based Pedestrian Detection Framework for Autonomous Driving Application.

Journal of visualized experiments : JoVE·2026
Same author

From recalcitrance to precision: a robust regeneration, transformation and targeted gene editing framework in <i>Cajanus cajan</i>.

Frontiers in genome editing·2026
Same author

Fermented beverage of <i>Ocimum tenuiflorum</i> ameliorates renovascular hypertension by the inhibition of ACE activity in 2K1C rat model.

3 Biotech·2026
Same author

A study of the utilization profile of donor corneas with a death-to-retrieval time of more than twelve hours.

Indian journal of ophthalmology·2026
Same journal

New Guidelines for Ophthalmic Genetic Studies.

Investigative ophthalmology & visual science·2026
Same journal

Genomic Copy Number Variants Associated With Strabismus and Amblyopia in the All of Us Research Program.

Investigative ophthalmology & visual science·2026
Same journal

Xanthophyll Carotenoid Intake, Plasma Levels, and Retinal Visualization in Aging and Age-Related Macular Degeneration: ALSTAR2.

Investigative ophthalmology & visual science·2026
Same journal

Enhanced Endocytosis and Mitochondrial Stress Underlie Severe Retinitis Pigmentosa With RHO P347L Mutant.

Investigative ophthalmology & visual science·2026
Same journal

Dual-Hit Myopia Mechanism Unveiled by Multi-Omics: Opn1mw Deficiency Primed the Retina for Exaggerated Response to Environmental Defocus.

Investigative ophthalmology & visual science·2026
Same journal

Psychometric Performance of Children With Amblyopia During a Tablet-Based Adaptive Visual Acuity Assessment.

Investigative ophthalmology & visual science·2026
See all related articles

Nonviral gene therapy targeting vimentin effectively reduced corneal opacity in a mouse model. This approach shows promise for treating corneal fibrosis and preventing vision loss from scarring.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Gene Therapy

Background:

  • Corneal fibrosis, a significant cause of visual impairment, results from wound-induced activation and differentiation of corneal keratocytes.
  • Vimentin, a type III intermediate filament, is crucial for keratocyte activation during the fibrotic process.

Purpose of the Study:

  • To develop and evaluate a nonviral gene therapeutic strategy for corneal fibrosis by targeting vimentin knockdown.
  • To assess the efficacy of targeting vimentin in reducing corneal opacity and scarring.

Main Methods:

  • Investigated plasmid expression duration in corneal keratocytes using a naked plasmid expressing green fluorescent protein (GFP).
  • Utilized a mouse corneal wound injury model, administering GFP or small hairpin RNA plasmids to evaluate opacification.
Keywords:
corneal fibroblastscorneal wound healingkeratocytes

More Related Videos

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
06:46

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies

Published on: February 15, 2019

11.5K
In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition
09:05

In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition

Published on: August 20, 2016

7.3K

Related Experiment Videos

Last Updated: Apr 29, 2026

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
11:49

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye

Published on: August 16, 2014

16.5K
Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
06:46

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies

Published on: February 15, 2019

11.5K
In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition
09:05

In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition

Published on: August 20, 2016

7.3K

Main Results:

  • Green fluorescent protein (GFP) expression was prominent for up to 15 days post-injection.
  • Vimentin knockdown significantly reduced corneal opacity compared to controls, with GFP-positive cells showing extensive intercellular connections.

Conclusions:

  • Nonviral gene therapy targeting vimentin is a viable strategy for treating corneal fibrosis.
  • This approach holds potential for reducing corneal scarring and preserving vision.